Current and emerging technologies to develop Point-of-Care Diagnostics in medical mycology

Takahiro Matsuo Sebastian Wurster Martin Hoenigl Dimitrios P. Kontoyiannis a Department of Infectious Diseases,Infection Control and Employee Health,The University of Texas MD Anderson Cancer Center,Houston,TX,USAb Division of Infectious Diseases,ECMM Excellence Center,Department of Internal Medicine,Medical University of Graz,Graz,Austriac Translational Medical Mycology Research Group,Medical University of Graz,Graz,Austriad Bio TechMed,Graz,Austria
DOI: https://doi.org/10.1080/14737159.2024.2397515
2024-09-20
Expert Review of Molecular Diagnostics
Abstract:Introduction Advances in diagnostic technologies, particularly Point-of-Care Diagnostics (POCDs), have revolutionized clinical practice by providing rapid, user-friendly, and affordable testing at or near the patient's location. POCDs have been increasingly introduced in medical mycology and hold promise to improve patient outcomes in a variety of important human fungal diseases.
pathology
What problem does this paper attempt to address?